InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Raymon Heather. Director active across 1 company, notably Artiva Biotherapeutics, Inc.. In total, 2 reports have been logged. Activity tracked since 12 September 2024. The latest transaction was disclosed on 26 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations